TriSalus Life Sciences, Inc. (TLSI) Gross profit 2022–2025
TriSalus Life Sciences, Inc. (TLSI) annual gross profit history from SEC filings — each fiscal year as reported.
$38.2MFY2025 · since FY2022: $10.1M → $38.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $38.2M | +50.8% |
| FY2024 | $25.3M | +59.2% |
| FY2023 | $15.9M | +56.9% |
| FY2022 | $10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Net marginTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →